Skip to content

PLEASE DONATE Now To Help Get the THIRD Clinical Trial Going!

Addi_360_120_TM

About
Science
Clinical
News
Investors

First Five Patients Show Critical Efficacy Markers

By Christopher | July 14, 2023

9713 Key West Ave, 5th Floor
Rockville, MD 20850
(301) 337-2100

Company

About
Science
News
Investors
Careers
Privacy

Contacts

Press
Investors
General

Updates

© 2025 Addimmune. All Rights Reserved.